Grasp the opportunity at Emerging Markets for High Growth of Life Science and Chemical...
The global life science and chemical instrumentation market will reach USD48.84 billion by 2019, with...
ICSE China 2016 – A gala event for pharma CRO & CMO industry
ICSE China 2016, hosted by UBM EMEA and China Chamber of Commerce of Medicines &...
Mersana Therapeutics and Takeda Expand Partnership to Advance Development of Fleximer Antibody-Drug
Mersana Therapeutics and Takeda Pharmaceutical Company Limited announced that they have entered a new strategic...
Changes to the Roche Corporate Executive Committee
Silvia Ayyoubi (62), Head of Group Human Resources for Roche and member of the Corporate...
Bristol-Myers Squibb and Pfizer Sign Collaboration with Portola Pharmaceuticals to Develop and Commercialize Investigational...
Bristol-Myers Squibb Company (NYSE:BMY) and Pfizer Inc. (NSYE:PFE) today announced that the companies have entered...
Bristol-Myers Squibb Foundation Awards Eight Grants Totaling Nearly $11.5M to Make Lung and Skin...
"The grant from the Bristol-Myers Squibb Foundation will allow us the opportunity to better reach...
U.S. FDA Accepts Filing Of Cardiovascular Outcomes Data For Jardiance® (Empagliflozin)
The U.S. FDA accepted a supplemental New Drug Application for Jardiance based on cardiovascular risk...
U.S. Food And Drug Administration Approves Humulin® R U-500 KwikPen®
The U.S. Food and Drug Administration (FDA) has approved Eli Lilly and Company's (NYSE: LLY)...
Lilly And Roche Diagnostics To Collaborate On Alzheimer’s Disease Adjunct Diagnostic ToolEli Lilly and...
Eli Lilly and Company (NYSE: LLY) today announced an arrangement to partner with Roche Diagnostics...
Bristol-Myers Squibb’s Opdivo (nivolumab) + Yervoy (ipilimumab) Regimen Receives Expanded FDA Approval in Unresectable...
Announcement in the U.S. that Food and Drug Administration (FDA) has approved Opdivo (nivolumab) in...
